Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-21-065138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-17 | 2021-11-16+ | TCRT | Boyle Kevin S. Sr. | CEO, Dir | P - Purchase | $1.40 | +10.0K | 885.0K | +1% | +$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | P | A | 884 | $1.40 | 875,884 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-17 | P | A | 9,116 | $1.40 | 885,000 | D | — | — |